Efthymios Deliargyris
CIK 1751617 · Chief Medical Officer · last filed 2025-08-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$189.1K
Companies
2
Total Filings
13
Lifetime Open-Market Net
$30.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CTSO | Chief Medical Officer | 473,025 | $0.40 | $189.1K | $30.0K | 10 | 2025-08-08 |
| PLx Pharma Inc. (PLXP) Delisted | Chief Medical Officer | — | $0.09 | — | $0 | 3 | 2020-03-24 |
Recent Filings · Page 2 of 2
13 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-03-24 | PLx Pharma Inc. (PLXP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-03-18 | PLx Pharma Inc. (PLXP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-08-31 | PLx Pharma Inc. (PLXP) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–13 of 13
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.